Bipolar Disorder Therapeutics Market
Bipolar Disorder Therapeutics Market Analysis by Type (Antipsychotics Drugs, Anticonvulsants, Mood Stabilizers, Antidepressant Drugs, Anti-anxiety Drugs), by Region - Global Forecast 2022-2026
Analysis of Bipolar Disorder Therapeutics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook of Bipolar Disorder Therapeutics
Demand for bipolar disorder therapeutic drugs is projected to increase at a CAGR of 3.1% from 2022 to 2026.
The global bipolar disorder therapeutics market will account for US$ 5.9 Bn in 2022, and is anticipated to reach a valuation of US$ 6.8 Bn by the end of 2026.
|
Report Attributes |
Details |
|---|---|
|
Bipolar Disorder Therapeutics Market Size (2022) |
US$ 5.9 Bn |
|
Projected Year Value (2026F) |
US$ 6.8 Bn |
|
Global Market Growth Rate (2022-2026) |
3.1% CAGR |
|
United States Market Share (2022) |
44.3% |
|
Key Companies Profiled |
|
Consumption of bipolar disorder medications in China is expected to account for a revenue of approximately US$ 514 Mn by the end of 2026.
Increasing prevalence of bipolar disorders and rising awareness regarding mental health are major trends that will driving demand for bipolar disorder therapeutics over the years to come.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis for Bipolar Disorder Therapeutics (2017-2021) in Comparison to Market Growth Forecasts (2022-2026)
The world has witnessed an increase in focus on mental health over the past few years and this has been majorly driven by increasing stress levels among the population across the globe.
Increasing awareness for bipolar disorders from government initiatives has majorly increased the demand for bipolar disorder medications and is expected to be a prominent trend over the forecast period.
High-stress environments and increasing incidence of substance abuse are major bipolar disorder causes. Rising public awareness about bipolar disorders, rapid advancements in therapeutics development, and increasing caseload of bipolar disorders are other factors that will influence bipolar disorder therapeutics consumption through 2026.
However, the side effects associated with the use of bipolar disorder therapeutic medications are anticipated to hinder market potential throughout the forecast period. From 2022 to 2026, demand for bipolar disorder therapeutics is projected to rise at a steady CAGR of 3.1%.
What Will Majorly Influence Bipolar Disorder Therapeutics Market Size through 2026?
“Increasing Prevalence of Mental Health Disorders across Geographies”
Over the past few years, the incidence of mental health disorders across the world has substantially increased and is expected to rise further over the forecast period.
Early onset of mental illnesses in teenagers and rising public awareness for mental health are major factors that influence bipolar disorder treatment market potential.
Demand for ADHD therapeutics, autism therapeutics, and seasonal affective disorder therapeutics is also expected to rise throughout the forecast period.
Will Related Side Effects Constrain Consumption of Bipolar Disorder Therapeutic Drugs?
“Rising Awareness about Side Effects of Bipolar Disorder Therapeutic Medications Could Hinder Market Growth”
Side effects associated with the use of bipolar disorder therapeutic medications are anticipated to have a restraining effect on global market potential.
Rising awareness among the general population regarding ill effects associated with long-term use of bipolar disorder drugs and increasing patient preference for chemical-free bipolar disorder medication are factors that could slow down bipolar disorder therapeutics demand over the coming years.
What is the Regional Market Outlook for Bipolar Disorder Therapeutics?
“North America Accounts for Major Market Share”
The market for bipolar disorder therapeutics is projected to have a bright outlook in the region of North America owing to rising instances of bipolar disorders. This region is anticipated to hold a dominant market share over the forecast period.
Increasing awareness for bipolar disorders, the presence of advanced an healthcare system, rising incidence of bipolar disorders due to high-stress environments, and poor lifestyle habits are major factors that influence bipolar disorder therapeutics market growth through 2026. Increasing incidence of ADHD (Attention-deficit Hyperactivity Disorder) in this region will drive ADHD therapeutics demand.
Europe bipolar disorder therapeutics market is also anticipated to hold a significant market share owing to rising awareness for mental health and supportive government initiatives to boost the same. Consumption of bipolar disorder therapeutics equipment in Germany is anticipated to evolve at a CAGR of 2.6% throughout the forecast period.
Increasing prevalence of mental disorders in regions of South Asia and East Asia is expected to provide lucrative opportunities for bipolar disorder therapeutics device providers across the forecast period. The bipolar disorder therapeutics market in China is estimated to attain a net value of US$ 514 Mn by 2026.
India and China are projected to emerge as highly rewarding markets in these regions as awareness of bipolar disorders increases through 2026. Rising instances of autism in the aforementioned region are expected to propel the demand for autism therapeutics.
Country-wise Insights
How Lucrative is the U.S. Bipolar Disorder Therapeutics Market?
“High Incidence of Bipolar Disorders to Market Potential in U.S.”
The U.S. bipolar disorder therapeutics market currently accounts for 44.3% of the global bipolar disorder therapeutics industry landscape.
Increasing prevalence of bipolar disorders and rising awareness of mental health are two major trends that will drive bipolar disorder therapeutics market growth through 2026.
Currently, the bipolar disorder therapeutics market in the U.S. holds a net worth of US$ 2.6 Bn.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Will Sales of Mood Stabilizers Increase through 2026?
“Increasing Maniac Episodes & Prevalence of Depression to Drive Demand”
Mania and depression due to mental disorders is a common phenomenon and is often signified by mood swings and sudden mood changes. In order to control these and restore neurochemical balance, mood stabilizers are used and since episodes of depression and mania are on the rise these are anticipated to see high demand.
China, the United States, Canada, and Japan are projected to account for major demand for mood stabilizers through 2026.
How Did the Bipolar Disorder Therapeutics Market Perform in 2020-2021?
The bipolar disorder therapeutics market saw a shift in trends as the sudden emergence of COVID-19 put the world in a state of shock. Lockdown restrictions were imposed across multiple nations as an effort to curb the spread of infections and this led to major changes in the world economy and affected various markets in different ways.
With a pandemic situation prevalent on a global scale and most of the world restricted from outdoor activity, a substantial change in mental health was observed under these challenging conditions. Although the demand for bipolar disorder medication was high in 2020, the market did not grow at its full potential owing to an increased focus on coronavirus infection control.
Allotment of major healthcare resources for pandemic led to a decreased focus on other health conditions and hence had a negative impact on the bipolar disorder therapeutics market growth. Consumption of bipolar disorder therapeutic drugs is expected to rise at a slow CAGR in the post-pandemic era owing to rising demand from the increasing caseload of mental health disorders.
Competitive Landscape:
Bipolar disorder treatment providers are investing in the research and development of novel therapeutics to expand their market presence across various regions. Bipolar disorder drug manufacturers are also pushing their offerings to get approvals from regulatory authorities.
- In April 2022, Intra-Cellular Therapies, a leading biopharmaceutical organization known for its therapeutics, announced that it had obtained approval for the new dosage strength of CAPLYTA. This drug has proved its efficiency in the treatment of bipolar disorders and will now be available in strengths of 10.5 mg and 21 mg capsules.
Key Segments Covered in Bipolar Disorder Therapeutics Industry Research
-
Bipolar Disorder Therapeutics Market by Type:
- Antipsychotics Drugs
- Anticonvulsants
- Mood Stabilizers
- Antidepressant Drugs
- Anti-anxiety Drugs
-
Bipolar Disorder Therapeutics Market by Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Bipolar Disorder Therapeutics Market Snapshot 1.2. Key Market Trends 1.3. Current Market & Future Potential 1.4. Fact.MR Recommendation 2. Market Overview 2.1. Market Segmentation 2.2. Market Indicators 2.3. Market Definitions 2.4. Market Dynamics 2.4.1. Drivers 2.4.2. Restraints 2.4.3. Opportunities 2.5. Porter’s Five Forces Analysis 2.6. Value Chain Analysis 2.6.1. List of Potential Customers 2.7. Global Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 3. COVID-19 Impact on Global Bipolar Disorder Therapeutics Market 4. Bipolar Disorder Therapeutics Market Outlook, by Region 5. Bipolar Disorder Therapeutics Market Trend Analysis, 2022-2026 5.1. By Region 6. Global Bipolar Disorder Therapeutics Market Analysis and Forecast, by Drug Class, 2022-2026 6.1. Introduction & Definitions 6.2. Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 6.2.1. Antipsychotics Drugs 6.2.2. Anticonvulsants 6.2.3. Mood Stabilizers 6.2.4. Antidepressant Drugs 6.2.5. Anti-anxiety Drugs 6.3. Global Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class 7. Global Bipolar Disorder Therapeutics Market Analysis and Forecast, by Region, 2022-2026 7.1. Key Findings 7.2. Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Region, 2022-2026 7.2.1. North America 7.2.2. Europe 7.2.3. Asia Pacific 7.2.4. Middle East & Africa 7.2.5. Latin America 7.3. Global Bipolar Disorder Therapeutics Market Attractiveness, by Region 8. North America Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 8.1. Key Findings 8.2. North America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 8.3. North America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 8.3.1. U.S. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 8.3.2. U.S. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 8.3.3. Canada Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 8.3.4. Canada Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 8.4. North America Bipolar Disorder Therapeutics Market Attractiveness Analysis 9. Europe Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 9.1. Key Findings 9.2. Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3. Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.3.1. Germany Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3.2. Germany Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.3.3. France Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3.4. France Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.3.5. U.K. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3.6. U.K. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.3.7. Italy Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3.8. Italy Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.3.9. Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 9.3.10. Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 9.4. Europe Bipolar Disorder Therapeutics Market Attractiveness Analysis 10. Asia Pacific Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 10.1. Key Findings 10.2. Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3. Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.3.1. China Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3.2. China Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.3.3. India Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3.4. India Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.3.5. Japan Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3.6. Japan Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.3.7. ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3.8. ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.3.9. Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 10.3.10. Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 10.4. Asia Pacific Bipolar Disorder Therapeutics Market Attractiveness Analysis 11. Latin America Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 11.1. Key Findings 11.2. Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 11.3. Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 11.3.1. Brazil Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 11.3.2. Brazil Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 11.3.3. Mexico Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 11.3.4. Mexico Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 11.3.5. Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 11.3.6. Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 11.4. Latin America Bipolar Disorder Therapeutics Market Attractiveness Analysis 12. Middle East & Africa Bipolar Disorder Therapeutics Market Analysis and Forecast, 2022-2026 12.1. Key Findings 12.2. Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 12.3. Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 12.3.1. GCC Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 12.3.2. GCC Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 12.3.3. South Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 12.3.4. South Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 12.3.5. Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026 12.3.6. Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026 12.4. Middle East & Africa Bipolar Disorder Therapeutics Market Attractiveness Analysis 13. Competition Landscape 13.1. Global Bipolar Disorder Therapeutics Market Share Analysis, by Company (2021) 13.2. Competition Matrix 13.2.1. Drug Class Mapping 13.3. Company Profiles (Details – Overview, Financials, Recent Developments, and Strategy) 13.3.1. AstraZeneca 13.3.1.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.1.2. Company Description 13.3.1.3. Business Overview 13.3.1.4. Financial Overview 13.3.1.5. Strategic Overview 13.3.2. Bristol-Myers Squibb Company 13.3.2.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.2.2. Company Description 13.3.2.3. Business Overview 13.3.2.4. Financial Overview 13.3.2.5. Strategic Overview 13.3.3. Eli Lilly and Company 13.3.3.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.3.2. Company Description 13.3.3.3. Business Overview 13.3.3.4. Financial Overview 13.3.3.5. Strategic Overview 13.3.4. Astellas Pharma Inc. 13.3.4.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.4.2. Company Description 13.3.4.3. Business Overview 13.3.4.4. Financial Overview 13.3.4.5. Strategic Overview 13.3.5. Allergan plc. 13.3.5.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.5.2. Company Description 13.3.5.3. Business Overview 13.3.5.4. Financial Overview 13.3.5.5. Strategic Overview 13.3.6. Johnson & Johnson 13.3.6.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.6.2. Company Description 13.3.6.3. Business Overview 13.3.6.4. Financial Overview 13.3.6.5. Strategic Overview 13.3.7. GlaxoSmithKline plc. 13.3.7.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.7.2. Company Description 13.3.7.3. Business Overview 13.3.7.4. Financial Overview 13.3.7.5. Strategic Overview 13.3.8. AbbVie Inc. 13.3.8.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.8.2. Company Description 13.3.8.3. Business Overview 13.3.8.4. Financial Overview 13.3.8.5. Strategic Overview 13.3.9. Pfizer Inc. 13.3.9.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.9.2. Company Description 13.3.9.3. Business Overview 13.3.9.4. Financial Overview 13.3.9.5. Strategic Overview 13.3.10. Novartis International AG. 13.3.10.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.10.2. Company Description 13.3.10.3. Business Overview 13.3.10.4. Financial Overview 13.3.10.5. Strategic Overview 13.3.11. Gedeon Richter Plc 13.3.11.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.11.2. Company Description 13.3.11.3. Business Overview 13.3.11.4. Financial Overview 13.3.11.5. Strategic Overview 13.3.12. Lundbeck A/S 13.3.12.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.12.2. Company Description 13.3.12.3. Business Overview 13.3.12.4. Financial Overview 13.3.12.5. Strategic Overview 13.3.13. Janssen Pharmaceutica N.V. 13.3.13.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.13.2. Company Description 13.3.13.3. Business Overview 13.3.13.4. Financial Overview 13.3.13.5. Strategic Overview 13.3.14. Otsuka America Pharmaceutical Inc. 13.3.14.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.14.2. Company Description 13.3.14.3. Business Overview 13.3.14.4. Financial Overview 13.3.14.5. Strategic Overview 13.3.15. Sumitomo Dainippon Pharma Co. Ltd. 13.3.15.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.15.2. Company Description 13.3.15.3. Business Overview 13.3.15.4. Financial Overview 13.3.15.5. Strategic Overview 13.3.16. Validus Pharmaceuticals LLC 13.3.16.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.16.2. Company Description 13.3.16.3. Business Overview 13.3.16.4. Financial Overview 13.3.16.5. Strategic Overview 14. Assumptions & Acronyms Used 15. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 2: Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 3: Global Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 4: Global Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 5: Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Region, 2022-2026
Table 6: Global Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Region, 2022-2026
Table 7: North America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 8: North America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 9: North America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 10: North America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 11: North America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country, 2022-2026
Table 12: North America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country, 2022-2026
Table 13: U.S. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 14: U.S. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 15: U.S. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 16: U.S. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 17: Canada Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 18: Canada Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 19: Canada Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 20: Canada Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 21: Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 22: Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 23: Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 24: Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 25: Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 26: Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 27: Germany Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 28: Germany Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 29: Germany Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 30: Germany Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 31: U.K. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 32: U.K. Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 33: U.K. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 34: U.K. Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 35: France Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 36: France Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 37: France Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 38: France Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 39: Italy Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 40: Italy Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 41: Italy Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 42: Italy Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 43: Spain Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 44: Spain Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 45: Spain Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 46: Spain Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 47: Russia & CIS Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 48: Russia & CIS Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 49: Russia & CIS Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 50: Russia & CIS Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 51: Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 52: Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 53: Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 54: Rest of Europe Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 55: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 56: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 57: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 58: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 59: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 60: Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 61: China Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 62: China Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 63: China Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 64: China Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 65: Japan Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 66: Japan Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 67: Japan Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 68: Japan Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 69: India Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 70: India Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 71: India Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 72: India Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 73: ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 74: ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 75: ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 76: ASEAN Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 77: Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 78: Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 79: Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 80: Rest of Asia Pacific Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 81: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 82: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 83: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 84: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 85: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 86: Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 87: Brazil Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 88: Brazil Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 89: Brazil Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 90: Brazil Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 91: Mexico Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 92: Mexico Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 93: Mexico Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 94: Mexico Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 95: Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 96: Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 97: Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 98: Rest of Latin America Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 99: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 100: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 101: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 102: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 103: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 104: Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Country and Sub-region, 2022-2026
Table 105: GCC Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 106: GCC Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 107: GCC Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 108: GCC Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 109: South Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 110: South Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 111: South Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 112: South Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 113: Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 114: Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Forecast, by Drug Class, 2022-2026
Table 115: Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
Table 116: Rest of Middle East & Africa Bipolar Disorder Therapeutics Market Value (Mn) Analysis, 2022-2026
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Bipolar Disorder Therapeutics Market Price Trend, by Region, 2022-2026 (US$/Ton)
Figure 2: Global Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 3: Global Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 4: Global Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 5: Global Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 6: Global Bipolar Disorder Therapeutics Market Value Share, by Region, 2022 and 2026
Figure 7: Global Bipolar Disorder Therapeutics Market Attractiveness, by Region
Figure 8: North America Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 9: North America Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 10: North America Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 11: North America Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 12: North America Bipolar Disorder Therapeutics Market Value Share, by Country, 2022 and 2026
Figure 13: North America Bipolar Disorder Therapeutics Market Attractiveness, by Country
Figure 14: Europe Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 15: Europe Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 16: Europe Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 17: Europe Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 18: Europe Bipolar Disorder Therapeutics Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 19: Europe Bipolar Disorder Therapeutics Market Attractiveness, by Country and Sub-region
Figure 20: Asia Pacific Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 21: Asia Pacific Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 22: Asia Pacific Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 23: Asia Pacific Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 24: Asia Pacific Bipolar Disorder Therapeutics Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 25: Asia Pacific Bipolar Disorder Therapeutics Market Attractiveness, by Country and Sub-region
Figure 26: Latin America Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 27: Latin America Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 28: Latin America Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 29: Latin America Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 30: Latin America Bipolar Disorder Therapeutics Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 31: Latin America Bipolar Disorder Therapeutics Market Attractiveness, by Country and Sub-region
Figure 32: Middle East & Africa Bipolar Disorder Therapeutics Market Value Share, by Drug Class, 2022 and 2026
Figure 33: Middle East & Africa Bipolar Disorder Therapeutics Market Attractiveness, by Drug Class
Figure 34: Middle East & Africa Bipolar Disorder Therapeutics Market Value Share, Analysis, 2022 and 2026
Figure 35: Middle East & Africa Bipolar Disorder Therapeutics Market Attractiveness, Analysis
Figure 36: Middle East & Africa Bipolar Disorder Therapeutics Market Value Share, by Country and Sub-region, 2022 and 2026
Figure 37: Middle East & Africa Bipolar Disorder Therapeutics Market Attractiveness, by Country and Sub-region
Figure 38: Global Bipolar Disorder Therapeutics Market Share Analysis, by Company, 2021
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the bipolar disorder therapeutics market enjoy currently?
The global bipolar disorder therapeutics market stands at US$ 5.9 Bn in 2022.
What will be the bipolar disorder therapeutics market revenue total by 2026?
By the end of 2026, the global market for bipolar disorder therapeutics is predicted to reach a valuation of US$ 6.8 Bn.
At what rate is the bipolar disorder therapeutics market projected to rise across the forecast period?
From 2022 to 2026, demand for bipolar disorder therapeutics is anticipated to progress at CAGR 3.1%.
Who are the key suppliers of bipolar disorder therapeutic drugs?
Key bipolar disorder therapeutic drug manufacturers are Astellas Pharma Inc., Allergan plc., Johnson & Johnson, GlaxoSmithKline plc., AbbVie Inc., Pfizer Inc., Novartis International AG., Gedeon Richter Plc, Lundbeck A/S, Janssen Pharmaceutica N.V., and O
What market share is held by the United States?
The U.S. bipolar disorder therapeutics market accounts for 44.3% of the global market share in 2022.
What will the China bipolar disorder therapeutics market be worth by 2026?
By 2026, the China bipolar disorder therapeutics market is anticipated to attain a net worth of US$ 514 Mn.
Bipolar Disorder Therapeutics Market